Ozempic Lawsuits Claim Drug Is Linked to Vision Loss
Weight loss drugs like Ozempic have been shown to decrease risks for various health problems, including heart and kidney disease, potentially generating billions in revenue for pharmaceutical companies over the coming decade.
However, in rare instances, GLP-1 agonists, the class of drugs to which Ozempic belongs, can lead to severe side effects. Most notably, blindness has been reported, prompting over 70 lawsuits against Novo Nordisk and Eli Lilly, the makers of Ozempic and Mounjaro, respectively, according to Reuters.
These lawsuits, filed in both state and federal courts, claim that the medications caused patients to develop non-arteritic anterior ischemic optic neuropathy. This condition involves a disruption of blood flow to the optic nerve, resulting in vision loss. Health tracking apps like Shotlee can help monitor for any sudden changes in vision, facilitating early detection and intervention.
A federal judicial panel recently approved the consolidation of these cases, assigning a Pennsylvania federal judge to oversee them. This decision paves the way for a significant legal battle with potentially far-reaching consequences for the future of these increasingly popular drugs.
Precision tracking for your journey
Join thousands using Shotlee to accurately track GLP-1 medications and side effects.
📱 Get the Shotlee App
Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!
Furthermore, the manufacturers of GLP-1 drugs face additional challenges beyond the blindness lawsuits. A separate series of legal actions alleges that these drugs can induce gastroparesis, a condition where the gastrointestinal tract's ability to move food for digestion is impaired.
The first GLP-1 agonist drug received approval from the US Food and Drug Administration (FDA) in 2005 as a treatment for diabetes. Subsequently, in 2021, the FDA authorized Novo Nordisk, the manufacturer of Ozempic, to produce and market Wegovy. Wegovy functions similarly to Ozempic but is specifically targeted towards individuals seeking weight loss.
That important decision, coupled with widespread positive media coverage, sparked the current enthusiasm for these weight loss medications. Celebrities such as Oprah and Rebel Wilson have reportedly experienced significant weight loss in a relatively short period using these drugs.
However, in recent years, an increasing number of individuals have reported experiencing serious side effects from using these medications. This has tempered some of the excitement surrounding drugs that were once promoted as a miracle cure for a wide array of ailments, including aging.
